Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
161,246
-
Share change
-
+72,176
-
Total reported value
-
$216,070
-
Price per share
-
$1.34
-
Number of holders
-
7
-
Value change
-
+$86,656
-
Number of buys
-
4
-
Number of sells
-
5
Institutional Holders of Sonnet BioTherapeutics Holdings, Inc. - COM NEW (SONN) as of Q1 2025
As of 31 Mar 2025 Sonnet BioTherapeutics Holdings, Inc. - COM NEW (SONN) had 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 161,246 shares of stock of the company.
Largest 7 holders included MMCAP International Inc. SPC, GEODE CAPITAL MANAGEMENT, LLC, Tower Research Capital LLC (TRC), UBS Group AG, BlackRock, Inc., Carolina Wealth Advisors, LLC, and BANK OF AMERICA CORP /DE/.
This table shows 7 institutional shareholders of the security as of 31 Mar 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.